| scholarly article | Q13442814 |
| P50 | author | Warren J. Manning | Q92757362 |
| P2093 | author name string | Ito K | |
| Feng X | |||
| Dillmann WH | |||
| Lorell BH | |||
| Yan X | |||
| P433 | issue | 5 | |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 422-429 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Transgenic expression of sarcoplasmic reticulum Ca(2+) atpase modifies the transition from hypertrophy to early heart failure | |
| P478 | volume | 89 |
| Q37357796 | A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids |
| Q34721028 | A mathematical model of the mouse ventricular myocyte contraction |
| Q33947442 | AFos dissociates cardiac myocyte hypertrophy and expression of the pathological gene program |
| Q34485808 | Ablation of phospholamban and sarcolipin results in cardiac hypertrophy and decreased cardiac contractility |
| Q37766138 | Advances in gene-based therapy for heart failure |
| Q33535920 | Alpha1A-adrenergic receptor-directed autoimmunity induces left ventricular damage and diastolic dysfunction in rats |
| Q33683757 | Altered intracellular Ca2+ handling in heart failure |
| Q48011111 | Anthracycline cardiotoxicity in transgenic mice overexpressing SR Ca2+-ATPase |
| Q83386744 | Aortic stenosis |
| Q37995502 | Assessment and management of aortic valve disease in patients with left ventricular dysfunction |
| Q44370057 | Calcium dynamics in the failing heart: restoration by beta-adrenergic receptor blockade |
| Q45063927 | Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction |
| Q34695565 | Compromised myocardial energetics in hypertrophied mouse hearts diminish the beneficial effect of overexpressing SERCA2a |
| Q52604700 | Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy. |
| Q33626525 | Cytosolic H2O2 mediates hypertrophy, apoptosis, and decreased SERCA activity in mice with chronic hemodynamic overload. |
| Q35825891 | Decreased cardiac SERCA2 expression, SR Ca uptake, and contractile function in hypothyroidism are attenuated in SERCA2 overexpressing transgenic rats |
| Q43892725 | Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophy |
| Q36081437 | Effects of Shenmai injection and its bioactive components following ischemia/reperfusion in cardiomyocytes |
| Q34467075 | Enhanced L-type calcium currents in cardiomyocytes from transgenic rats overexpressing SERCA2a |
| Q36944623 | Gene therapy in heart failure |
| Q27022444 | Gene therapy targets in heart failure: the path to translation |
| Q33605156 | Heart failure management: the present and the future |
| Q33220814 | Impaired intracellular Ca2+ dynamics in live cardiomyocytes revealed by rapid line scan confocal microscopy |
| Q42527073 | Interaction between increased SERCA2a activity and beta -adrenoceptor stimulation in adult rabbit myocytes. |
| Q36244487 | Loss of Rad-GTPase produces a novel adaptive cardiac phenotype resistant to systolic decline with aging. |
| Q36422429 | Low-dose radiation affects cardiac physiology: gene networks and molecular signaling in cardiomyocytes. |
| Q38187952 | Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart |
| Q46104597 | Modulation of actin isoform expression before the transition from experimental compensated pressure-overload cardiac hypertrophy to decompensation |
| Q35935868 | Murine models for the study of congestive heart failure: Implications for understanding molecular mechanisms and for drug discovery |
| Q34313853 | Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy |
| Q42022131 | Oxidative posttranslational modifications mediate decreased SERCA activity and myocyte dysfunction in Galphaq-overexpressing mice |
| Q58816586 | Regression of pressure overload-induced left ventricular hypertrophy in mice |
| Q37608521 | Regulation of myocardial SERCA2a expression in ventricular hypertrophy and heart failure |
| Q33787794 | Rescue of familial cardiomyopathies by modifications at the level of sarcomere and Ca2+ fluxes |
| Q37996857 | Rodent models of heart failure: an updated review. |
| Q37054922 | Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation |
| Q37229784 | The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases |
| Q41961959 | The role of SUMO-1 in cardiac oxidative stress and hypertrophy. |
| Q28207738 | Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance |
| Q33890891 | Treatment of heart failure by a methanocarba derivative of adenosine monophosphate: implication for a role of cardiac purinergic P2X receptors. |
| Q40199219 | Treatment of heart failure by calcium cycling gene therapy |
| Q41950435 | β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure |
Search more.